Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-04-15
1999-08-10
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514423, A61K 3800
Patent
active
059359242
ABSTRACT:
A mammal with congestive heart failure is treated by administering to the mammal an effective amount of growth hormone. Treatment results in increased left ventricular cystolic pressure, increased left ventricular maximum, increased cardiac output, and increased stroke volume index. Treatment also results in reduced left ventricular end-diastolic pressure and reduced systemic vascular resistance. These measurements indicate improvement in cardiac function by increased ventricular contractility and decreased peripheral vascular resistance.
REFERENCES:
patent: 5370870 (1994-12-01), Wong
Yang et al., "Effects of Growth Hormone in Rats with Postinfarction Left Ventricular Dysfunction" Cardiovascular Drugs and Therapy 9:125-131 (1995).
Amato et al., "Body Composition, Bone Metabolism, and Heart Structure and Function in Growth Hormone (GH)-Deficient Adults before and after GH Replacement Therapy at Low Doses", J. Clin. Endocrinol Metab., 77:1671-76 (1993).
Ambler et al., "Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor I", Cardiovascular Research, 27:1368-1373 (1993).
Buttrick et al., Effects of chronic dobutamine on cardiac mechanics and biochemistry after myocardial infarction in rats, Am. J. Physiol 260:11473-11479 (1991).
Caidahl et al., "Cardiovascular and renal effects of growth hormone", Clinical Endocrinology 40:393-400 (1994).
The Captopril-Digoxin Multicenter Research Group, "Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart Failure", JAMA 259(4):539-544 (1988).
Captopril Multicenter Research Group, "A Placebo-Controlled Trial of Captopril in Refractory Chronic Congestive Heart Failure", JACC 2(4):755-763 (1983).
Castagnino et al., "Bivalent Effects of Human Growth Hormone in Experimental Myocardial Infarcts; Protective When Administered Alone and Aggravating When Combined with Beta Blockers", 31:845-855 (1990).
Castagnino et al., "Preservation of the myocardial collagen framework by human growth hormone in experimental infarctions and reduction in the incidence of ventricular aneurysms", Int. J. Cardiol. 35:101-114 (1992).
Celniker et al., "Variability in the Quantitation of Circulating Growth Hormone Using Commercial Immunoassays", J.Endocrinology/Metabolism 68:469-476 (1989).
Christiansen et al., "Beneficial effects of GH replacement therapy in adults", Acta Endocrinol. 125:7-13 (1991).
Clemmons et al., "Reversal of Diet-Induced Catabolism by Infusion of Recombinant Insulin-Like Growth Factor-I in Humans", J. Clin Endocrinol 75:234-238 (1992).
Cohn et al., "A Comparison of Enalapril with Hydralazine-Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure", The New England Journal of Medicine, 325(5):303-310 (1991).
The Consensus Trial Study Group, "Effects of Enalapril on Mortality in Severe Congestive Heart Failure", The New England Journal of Medicine 316 (23):1429-1435 (1987).
Csanady et al., "The heart in acromegaly: an echocardiographic study", Int. J. Cardiol 2:349-361 (1983).
Fazio et al., "Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study", Eur Heart J. 14:26-33 (1993).
Florini, "Hormonal Control of Muscle Growth", Muscle & Nerve 10:577-598 (1987).
Froesch et al., "Therapeutic Potential of Insulinlike Growth Factor I", Trends in Endocrinology/Metabolism 1(5):254-260 (1990).
Furlanetto et al., "Estimation of Somatomedin-C Levels in Normals and Patients with Pituitary Disease by Radioimmunoassay", The Journal of Clinical Investigation 60:648-657 (1977).
Geenen et al., "Papillary mechanics and cardiac morphology of infarcted rat hearts after training", J. Appl. Physical, 63:92-96 (1987).
Guler et al., "Short-Term Metabolic Effects of Recombinant Human Insulin-Like Growth Factor I in Healthy Adults", The New England Journal of Medicine 317(3):137-140 (1987).
Kahaly et al., "Arrhythmia profile in acromegaly", Eur Heart J. 13:51-56 (1992).
Kloner et al., "The effect of early exercise on myocardial infarct scar formation", Amer. Heart Journal 106(5):1009-1013 (1983).
Kramer et al., "Controlled Trial of Captopril in Chronic Heart Failure: A Rest and Exercise Hemodynamic Study", Circulation 67(4):807-816 (1983).
Kupfer et al., "Enhancement of the Anabolic Effects of Growth Hormone and Insulin-Like Growth Factor I by Use of Both Agents Simultaneously", Amer. Soc. for Clin. Invest. 91:391-396 (1983).
Lei et al., "Cardiac Architectural Changes with Hypertrophy Induced by Excess Growth Hormone in Rats", Lab Invest., 59:357-362 (1988).
Lim et al., "Rapid Reduction of Left Ventricular Hypertrophy in Acromegaly after Suppression of Growth Hormone Hypersecretion", Ann Intern Med., 117:719-726 (1992).
Merola et al., "Cardiac Structural and Functional Abnormalities in Adult Patients with Growth Hormone Deficiency", J. Clin. Endocrinol Metab 77:1658-1661 (1993).
Metcalfe et al., "Metabolic Effects of Acute and Prolonged Growth Hormone Excess in Normal and Insulin-deficient Man", Diabetologia 20:123-128 (1981).
Pollock et al., "Usefulness of Bucindolol in Congestive Heart Failure", Am J Cardiol 66:603-607 (1990).
Shahi et al., "Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality", Br Heart J 67:92-96 (1992).
Sherwin et al., "Effect of Growth Hormone on Oral Glucose Tolerance and Circulating Metabolic Fuels in Man", Diabetologia 24:155-161 (1983).
Sicolo et al., "Acromegalic cardiopathy: A left ventricular scintigraphic study", J. Endocrinol. Invest. 16:123-127 (1993).
The SOLVD Investigators, "Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure", The New England Journal of Medicine 325(5):293-302 (1991).
Takano et al., "Effects of sc Administration of Recombinant Human Insulin-Like Growth Factor I (IGF-I) on Normal Human Subjects", Endocrinol. Japon. 37(2):309-317 (1990).
Vetter et al., "Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro", Basic Res. Cardiol 83:647-654 (1988).
Yang, R. et al., "J. Heart Failure", Abstract Suppl 1:793 (1993).
Banskota et al., "Characterization of Induction of Protooncogene c-myc and Cellular Growth in Human Vascular Smooth Muscle Cells by Insulin and IGF-I" Diabetes 38:123-129 (1989).
Beznak, "The Restoration of Cardiac Hypertrophy and Blood Pressure in Hypophysectomized Rats by Large Doses of Lyophilized Anterior Pituitary and Growth Hormone" J. Physiol. (Lond.) 124:64-74 (1954).
Boulware et al., "Diverse Effects of Insulin-like Growth Factor I on Glucose, Lipid, and Amino Acid Metabolism" Am. J. Physiol. 262:E130-E133 (1992).
Bugaisky et al., "Cellular and Molecular Mechanisms of Cardiac Hypertrophy" The Heart and Cardiovascular System 2:1621-1640 (1992).
Caidahl et al., "Cardiovascular and Renal Effects of Growth Hormone" Acta Endocrinologica 128(Suppl. 2):68 (1993).
Chanson et al., "Cardiovascular Effects of the Somatostatin Analog Octreotide in Acromegaly" Annals Int. Med. 113:921-925 (1990).
Cittadini et al., "Impaired Cardiac Performance in GH-Deficient Adults and its Improvement after GH Replacement" Am. J. Physiol. 267:E219-E225 (1994).
Cuneo et al., "Cardiac Failure Responding to Growth Hormone" Lancet pp. 838-839 (1989).
Cuneo et al., "Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system" Clinical Science 81:587-592 (1991).
Cuneo et al., "Growth Hormone Treatment Improves Serum Lipids and Lipoproteins in Adults with Growth Hormone Deficiency" Metabolism 42(12):1519-1523 (Dec. 1993).
Donohue et al., "Evidence that Antihypertensive Agents Lessen Ventricular Hypertrophy by Inhibiting Cardiac Expression of Insulin-like Growth Factor-I" J. Am. Coll. Cardiol. 19:85A (Mar. 1992).
Donohue et al., "Induction of Myocardial Insulin-like Growth Factor-I Gene Expression in Left Ventricular Hypertrophy" Circulation 89(2):799-809 (1994).
Flyvbjerg et al., "Inhibitory Effect of Octreotide on Growth Hormone-Induced IGF-I Generation and Orga
Bunting Stuart
Clark Ross
Gillett Nancy
Jin Hongkui
Yang Renhui
Genentech Inc.
Hasak Janet E.
MacMillan Keith D.
LandOfFree
Treatment of congestive heart failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of congestive heart failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of congestive heart failure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1120094